Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5905

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 50090-5905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biso Api Structure (Api Pic New1)

Biso Api Structure (Api Pic New1)
Chemical structure of Bisoprolol Fumarate and Hydrochlorothiazide active ingredients, showing molecular configurations and bonding patterns for these compounds.*
FDA Label Image

Hctz Api Structure (Api Pic New2)

Hctz Api Structure (Api Pic New2)
Chemical structure of the active ingredient bisoprolol fumarate and hydrochlorothiazide showing a benzene ring with chlorine, sulfonamide, and amino substituents.*
FDA Label Image

1 (Table1 New)

1 (Table1 New)
A data table titled 'Sitting Systolic/Diastolic Pressure (BP) and Heart Rate (HR) Mean Decrease After 3 to 4 Weeks' showing results from two studies. It compares placebo and various doses of Bisoprolol Fumarate and Hydrochlorothiazide, presenting sample sizes, total blood pressure changes (mm Hg), drug effects, and heart rate changes (bpm). The table includes observed mean change from baseline minus placebo.*
FDA Label Image

1 (Table 2new)

1 (Table 2new)
A table presenting the percentage of patients experiencing adverse experiences categorized by body system, comparing placebo and Bisoprolol Fumarate and Hydrochlorothiazide 10 mg/6.25 mg tablets. It includes all adverse experiences and drug-related adverse experiences across multiple systems such as cardiovascular, respiratory, central nervous system, musculoskeletal, psychiatric, and gastrointestinal.*
FDA Label Image

1 (Table 3new)

1 (Table 3new)
A data table titled "Serum Potassium Data from U.S. Placebo Controlled Studies" comparing potassium mean change (mEq/L) and hypokalemia percentages across five groups: Placebo, B2.5/H6.25 mg, B5/H6.25 mg, B10/H6.25 mg, and HCTZ 25 mg. The table lists the number of participants and numeric results for each group.*
FDA Label Image

Label Image (Lbl500905905)

Label Image (Lbl500905905)
Label for Bisoprolol Fumarate and Hydrochlorothiazide 10 mg/6.25 mg film-coated tablets from A-S Medication Solutions. The label indicates 30 tablets in the package, with storage instructions to keep at 68 to 77 degrees Fahrenheit. It includes the product NDC 50090-5905-0 and dispensing instructions as a prescription medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.